Moderna, Inc. (MRNA)
148.99
+8.65
(+6.16%)
USD |
NASDAQ |
Sep 01, 13:22
Moderna Free Cash Flow : -1.244B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.244B |
| March 31, 2026 | -1.603B |
| December 31, 2025 | -2.075B |
| September 30, 2025 | -2.663B |
| June 30, 2025 | -3.50B |
| March 31, 2025 | -4.034B |
| December 31, 2024 | -4.055B |
| September 30, 2024 | -3.956B |
| June 30, 2024 | -3.979B |
| March 31, 2024 | -3.672B |
| December 31, 2023 | -3.825B |
| September 30, 2023 | -2.657B |
| June 30, 2023 | -754.00M |
| March 31, 2023 | 612.00M |
| December 31, 2022 | 4.581B |
| September 30, 2022 | 6.201B |
| Date | Value |
|---|---|
| June 30, 2022 | 9.215B |
| March 31, 2022 | 13.03B |
| December 31, 2021 | 13.34B |
| September 30, 2021 | 11.39B |
| June 30, 2021 | 9.083B |
| March 31, 2021 | 5.008B |
| December 31, 2020 | 1.960B |
| September 30, 2020 | 613.82M |
| June 30, 2020 | -373.44M |
| March 31, 2020 | -450.10M |
| December 31, 2019 | -489.55M |
| September 30, 2019 | -489.50M |
| June 30, 2019 | -483.79M |
| March 31, 2019 | -445.20M |
| December 31, 2018 | -436.63M |
| September 30, 2018 | -446.86M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | 58.34M |
| BioNTech SE | 424.34M |
| Kailera Therapeutics, Inc. | -- |
| Twist Bioscience Corp. | -93.22M |
| Revolution Medicines, Inc. | -1.232B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -526.00M |
| Cash from Investing (Quarterly) | 329.00M |
| Cash from Financing (Quarterly) | 14.00M |
| Free Cash Flow Per Share (Quarterly) | -1.415 |
| Free Cash Flow to Equity (Quarterly) | -552.00M |
| Free Cash Flow to Firm (Quarterly) | -545.67M |
| Free Cash Flow Yield | -2.12% |